Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03184545 · ClinicalTrials.gov registry record · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
A Phase 3 study of Patellofemoral Pain Syndrome, sponsored by Northwell Health.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT03184545: Recruiting Phase 3 study of Patellofemoral Pain Syndrome, sponsored by Northwell Health.
NCT03184545 is a Phase 3 study of Patellofemoral Pain Syndrome that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 92 participants, below the 137-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03184545, a Phase 3 study of Patellofemoral Pain Syndrome, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of study is to evaluate the efficacy of the electrical muscle stimulation (EMS) device in patients with patellofemoral pain known as anterior knee pain. Usual treatment for it is physical therapy (PT). We want to evaluate and see if adding the electrical muscle stimulation will fasten the recovery and improved outcome in patellofemoral pain syndrome. Half of participants will receive EMS and PT while other half will receive PT only.
Primary Outcome
Assessment will be done at each visit (pre-treatment, post-start treatment 3 weeks,, 6 weeks, 12 weeks, 6 months and 12 months) based on Kujala patellofemoral score. The Kujala score assesses following points: Limp, support, walking, stairs, squatting,running, jumping, prolong sitting with knee flexed,pain,swelling,abnormal painful kneecap movements, atrophy of thigh and flexion deficiency. Repeated measures linear regression models will be used to compare the two treatment arms with respect to
Conditions Studied
Interventions
- OTHER Physical therapy
- DEVICE EMS
Study Locations (1)
New York
- New York Bone and Joint Specialists - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2017-07-24 |
| Est. Completion | 2027-06 |
| Phase | Phase 3 |
What NCT03184545 shows while recruiting
NCT03184545 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 137-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Patellofemoral Pain Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Physical therapy is the first listed.
NCT03184545 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03184545 about?
NCT03184545 is a clinical study titled "Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome". The purpose of study is to evaluate the efficacy of the electrical muscle stimulation (EMS) device in patients with patellofemoral pain known as anterior knee pain. Usual treatment for it is physical therapy (PT). We want to evaluate and see if adding the electrical muscle stimulation will fasten th...
What is the current status of trial NCT03184545?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 92 participants. The study started on 2017-07-24. Estimated completion is 2027-06.
What conditions does trial NCT03184545 study?
This clinical trial studies the following conditions: Patellofemoral Pain Syndrome.
What interventions are being tested in trial NCT03184545?
The interventions under investigation include: Physical therapy (OTHER), EMS (DEVICE).
Who is sponsoring clinical trial NCT03184545?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03184545 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patellofemoral Pain Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03184545's enrollment target sits among peer trials
92 4th of 10 higher than 7 of 10 other Patellofemoral Pain Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Patellofemoral Pain Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindful Miles Pilot Feasibility Study
RECRUITING · NA
-
The Effects of Dry Needling on Patients With Knee Pain
RECRUITING · NA
-
Emovi 3D Knee Assessment Device Intervention for Operational Readiness
RECRUITING · NA
-
Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain
RECRUITING · NA
-
MRI Study of Musculoskeletal Function
RECRUITING
-
Trial of Neurostimulation and Blood Flow Restriction for PFPS in Active Duty
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- NCT05163639 · 92 participants · Early Phase 1
Spinal Cord Associative Plasticity Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI